Calamos Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.24M Sell
78,128
-1,452
-2% -$168K 0.03% 434
2026
Q1
$9.51M Hold
79,580
0.03% 415
2025
Q4
$10.8M Sell
79,580
-3,231
-4% -$465K 0.04% 374
2025
Q3
$12.2M Hold
82,811
0.05% 367
2025
Q2
$10.7M Hold
82,811
0.04% 392
2025
Q1
$9.89M Buy
82,811
+922
+1% +$114K 0.04% 394
2024
Q4
$9.5M Hold
81,889
0.04% 404
2024
Q3
$11.1M Sell
81,889
-2,009
-2% -$269K 0.05% 383
2024
Q2
$11.4M Sell
83,898
-3,062
-4% -$417K 0.05% 368
2024
Q1
$11.2M Sell
86,960
-2,187
-2% -$264K 0.05% 374
2023
Q4
$10.2M Sell
89,147
-1,164
-1% -$116K 0.05% 387
2023
Q3
$8.22M Sell
90,311
-568
-0.6% -$58.6K 0.04% 447
2023
Q2
$10.2M Hold
90,879
0.05% 412
2023
Q1
$9.52M Sell
90,879
-11,452
-11% -$1.2M 0.05% 452
2022
Q4
$11.3M Sell
102,331
-17,964
-15% -$1.88M 0.05% 430
2022
Q3
$10.5M Buy
120,295
+8
+0% +$727 0.05% 453
2022
Q2
$9.4M Buy
120,287
+3,206
+3% +$265K 0.04% 524
2022
Q1
$9.98M Buy
117,081
+16,106
+16% +$1.54M 0.04% 530
2021
Q4
$12.1M Buy
100,975
+3,904
+4% +$485K 0.05% 435
2021
Q3
$12M Buy
97,071
+8,688
+10% +$1.12M 0.05% 375
2021
Q2
$10.6M Buy
88,383
+20,103
+29% +$2.3M 0.05% 384
2021
Q1
$7.18M Buy
68,280
+2,110
+3% +$214K 0.04% 423
2020
Q4
$6.74M Sell
66,170
-2,865
-4% -$269K 0.04% 424
2020
Q3
$5.81M Sell
69,035
-6,059
-8% -$472K 0.04% 426
2020
Q2
$4.88M Sell
75,094
-4,805
-6% -$317K 0.03% 450
2020
Q1
$5.2M Sell
79,899
-6,702
-8% -$528K 0.04% 391
2019
Q4
$6.82M Sell
86,601
-1,426
-2% -$111K 0.03% 457
2019
Q3
$7.01M Buy
88,027
+7,640
+10% +$600K 0.04% 433
2019
Q2
$6.72M Buy
80,387
+4,002
+5% +$319K 0.04% 440
2019
Q1
$6.04M Buy
76,385
+767
+1% +$56K 0.04% 419
2018
Q4
$5.04M Buy
75,618
+11,322
+18% +$783K 0.03% 437
2018
Q3
$5.13M Sell
64,296
-14,115
-18% -$1.05M 0.03% 453
2018
Q2
$5.28M Sell
78,411
-6,846
-8% -$497K 0.03% 424
2018
Q1
$6.56M Buy
85,257
+4,000
+5% +$296K 0.04% 382
2017
Q4
$5.54M Sell
81,257
-1,620
-2% -$108K 0.03% 373
2017
Q3
$5.19M Buy
82,877
+3,040
+4% +$182K 0.04% 359
2017
Q2
$4.42M Buy
79,837
+11,128
+16% +$580K 0.03% 398
2017
Q1
$3.45M Sell
68,709
-3,026
-4% -$147K 0.03% 410
2016
Q4
$3.55M Buy
+71,735
New +$3.64M 0.03% 394
2016
Q2
Sell
-5,740
Closed -$235K 645
2016
Q1
$235K Hold
5,740
﹤0.01% 599
2015
Q4
$210K Buy
+5,740
New +$208K ﹤0.01% 639
2015
Q2
Sell
-6,945
Closed -$243K 725
2015
Q1
$243K Buy
+6,945
New +$245K ﹤0.01% 658
2014
Q3
Sell
-39,110
Closed -$1.53M 675
2014
Q2
$1.53M Sell
39,110
-43,625
-53% -$1.63M 0.01% 477
2014
Q1
$3.01M Sell
82,735
-30,650
-27% -$1.12M 0.02% 390
2013
Q4
$3.92M Buy
113,385
+46,525
+70% +$1.5M 0.02% 346
2013
Q3
$1.87M Sell
66,860
-12,950
-16% -$345K 0.01% 422
2013
Q2
$2.15M Buy
+79,810
New +$2.2M 0.01% 388

Other funds holding XYL

Calamos Advisors's XYL Position: Q2 2026 in Review

Calamos Advisors reduced its Xylem (XYL) stake by 1.8% in Q2 2026, selling an estimated $168K and leaving 78,128 shares worth $9.24M. The position accounts for 0.03% of the portfolio, ranked #434.

Calamos Advisors first reported a position in XYL in Q2 2013 and has held it in 47 quarters since. The position peaked at $12.2M in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Calamos Advisors held 78,128 shares of Xylem worth $9.24M as of Q2 2026.
  • Calamos Advisors sold 1,452 Xylem shares in Q2 2026, an estimated $168K.
  • Xylem made up 0.03% of Calamos Advisors's portfolio in Q2 2026, its #434 holding.
  • Calamos Advisors first reported a position in Xylem in Q2 2013 and has held it in 47 quarters since.
  • Calamos Advisors's Xylem position peaked at $12.2M in Q3 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.